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bjectives The aim of this study was to compare the procedural and clinical outcomes of femoral
rterial access with ultrasound (US) guidance with standard ﬂuoroscopic guidance.
ackground Real-time US guidance reduces time to access, number of attempts, and complications
n central venous access but has not been adequately assessed in femoral artery cannulation.
ethods Patients (n  1,004) undergoing retrograde femoral arterial access were randomized 1:1
o either ﬂuoroscopic or US guidance. The primary end point was successful common femoral artery
CFA) cannulation by femoral angiography. Secondary end points included time to sheath insertion,
umber of forward needle advancements, ﬁrst pass success, accidental venipunctures, and vascular
ccess complications at 30 days.
esults Compared with ﬂuoroscopic guidance, US guidance produced no difference in CFA cannu-
ation rates (86.4% vs. 83.3%, p  0.17), except in the subgroup of patients with CFA bifurcations
ccurring over the femoral head (82.6% vs. 69.8%, p  0.01). US guidance resulted in an improved
rst-pass success rate (83% vs. 46%, p  0.0001), reduced number of attempts (1.3 vs. 3.0, p  0.0001),
educed risk of venipuncture (2.4% vs. 15.8%, p  0.0001), and reduced median time to access (136 s vs.
48 s, p  0.003). Vascular complications occurred in 7 of 503 and 17 of 501 in the US and ﬂuoroscopy
roups, respectively (1.4% vs. 3.4% p  0.04).
onclusions In this multicenter randomized controlled trial, routine real-time US guidance im-
roved CFA cannulation only in patients with high CFA bifurcations but reduced the number of at-
empts, time to access, risk of venipunctures, and vascular complications in femoral arterial access.
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752ascular complications are the most common complications
f diagnostic and interventional catheterization procedures
erformed from the femoral approach, occurring in 1.5% to
% of patients (1,2). Bleeding complications and transfu-
ions have been associated with increased morbidity, mor-
ality, and health care costs (2,3).
Access complications are associated with female sex,
xtremes of weight, renal insufficiency, anticoagulation, and
he use of glycoprotein IIb/IIIa inhibitors (1,4). Multiple
etrospective studies have associated inappropriate puncture
ocations with an increased risk of complications. Cannula-
ion above the inguinal ligament is associated with retro-
eritoneal hemorrhage (5–7), whereas insertion below the
ommon femoral artery (CFA) bifurcation is associated
ith pseudoaneurysm and arteriovenous fistula formation
8,9). Proper CFA cannulation is required for the safe
eployment of most vascular closure devices.
The use of fluoroscopic guidance has been widely recom-
ended, on the basis of the observation that 65% of femoral
rtery bifurcations occur below the inferior border of the
emoral head (9,10), to potentially reduce complications
11). However, despite nonrandomized data supporting its
se (12), 3 recent randomized trials failed to demonstrate a
benefit for fluoroscopic guidance
in non-CFA cannulations or
clinical complications compared
with the use of anatomical land-
marks alone (10,13,14).
Ultrasound guidance has been
widely used for central venous
access in the last decade. In mul-
iple randomized trials and 2 meta-analyses, real-time US
uidance has been shown to reduce complications, number
f attempts, and time to access in central venous cannulation
15,16). Routine use of US guidance has been recom-
ended by the National Institute of Clinical Effectiveness
U.K.) and Agency for Healthcare Research and Quality
U.S.) for central venous line placement (17,18) and has
ecome the standard of care. Despite this, no large study of
S guidance has been conducted for femoral arterial
rocedures.
We sought to define the utility of US guidance in femoral
rterial access with a multicenter randomized controlled
rial with the most modern equipment. We hypothesized
hat US guided access would be superior to conventional
uoroscopic guided access with regard to accuracy and
elated access site complications.
ethods
tudy design. FAUST (Femoral Arterial Access With Ul-
rasound Trial) was a prospective, randomized, single-
linded trial conducted at 4 U.S. medical centers (1 private
bbreviations
nd Acronyms
FA  common femoral
rtery
S  ultrasoundonprofit, 2 university, and 1 government). The trial was pnvestigator-initiated, -designed, and -conducted. Research
aterials were supplied by the sponsor, who had no role in
he design, analysis, or publication of the trial. The FAUST
rotocol was approved by the institutional review board of
ach participating medical center.
atient population. Patients older than 18 years of age
cheduled to undergo a diagnostic or interventional coro-
ary or peripheral procedure from the retrograde femoral
rterial approach were eligible for enrollment in the trial.
atient enrollment required the availability of a dual-trained
rimary operator, ultrasound machine, and research coordi-
ator and thus was nonconsecutive.
Patients were excluded from the trial if they: 1) had
onpalpable femoral pulses; 2) had a creatinine of 3.0
g/dl, unless already receiving dialysis; 3) had an ST-
egment elevation myocardial infarction or unstable non–
T-segment elevation myocardial infarction; 4) were preg-
ant; or 5) were incarcerated. All enrolled patients gave
ritten informed consent to be included in the trial.
evice descriptions. The Site Rite 5 and Site Rite 6
ltrasound Systems (Bard Access, Inc., Salt Lake City,
tah) are equipped with variable 5- to 10-MHz linear array
S transducers capable of imaging to a depth of up to 6 cm.
he device has a large 12-  13-inch screen that is easily
een across the catheterization table. The probe is covered
ith a clear disposable sterile cover supplied with US
ransmission gel. An optional needle guide (Product
9001C0212, Bard Access) mounts onto the probe and fixes
he path of a standard 18-gauge needle in 3 dimensions.
The Acuson Cypress US machine (Siemens Medical
maging, Malvern, Pennsylvania) was used for 5% of US
rocedures, when a Site Rite was unavailable. The 7L3
ascular transducer transmits at a variable 4.3/5.4/6.6 MHz,
roviding adequate imaging but without the benefit of a
eedle guide.
perator training. Participating cardiology fellows and at-
ending physicians received instruction on the study proto-
ol and access techniques. For fluoroscopy patients, opera-
ors were instructed to attempt to cannulate the femoral
rtery at the center of the femoral head by marking its
ocation with a radiopaque clamp and puncturing the skin 2
o 3 cm inferiorly. Training in US included lecture discus-
ion and brief practice sessions on both gelatin models and
ive patients. Operators were instructed to aim for an
nsertion above the bifurcation with US (Fig. 1) and use
natomical landmarks to insert over the femoral head. A
inimum of 3 proctored US-guided procedures were re-
uired before participation as a primary operator.
andomization. Patients were randomized in a 1:1 fashion
o either US or fluoroscopic guidance, with sealed envelopes
alanced in groups of either 50 or 80 by each center.
atients were not randomized until a single dual-trained
rimary operator was assigned to their care.
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753rocedure. After being draped, all patients received manual
alpation of anatomic landmarks: the anterior superior iliac
pine, pubic symphysis, and the femoral pulse. For fluoros-
opy patients, a radio-opaque marker was placed on the skin
bove the femoral head, and an anterior/posterior projection
sed to localize the femoral head relative to the marker. For
S patients, the US machine was set up and draped, with
ransmission gel applied. If chosen by the operator, a needle
uide was attached, and a needle was loaded. The US
maging was performed in the axial plane. The modified
eldinger technique was intended to be used in all cases.
The number of attempts required for sheath insertion and
he number of accidental venipunctures was recorded by the
perator and an independent observer. Attempts were
efined as a forward motion separated by any withdrawal of
he needle. If a fellow was involved, the attending physician
as asked to allow 5 attempts before taking over the
rocedure. Time to access was recorded by lab staff from the
rst movement of the table for fluoroscopy or the first
pplication of the US probe, until the sheath was success-
ully inserted. Time for sterile preparation of the field and
S probe was not included. If an operator preferred to
dminister local anesthetic after localization by fluoroscopy
r US, they were instructed to do so for all study patients
egardless of randomization assignment. Nicking of the
kin, dermotomy, or repeated fluoroscopy was performed by
Figure 1. Ultrasound Guidance Technique
(A) The attached needle guide ﬁxes the needle’s angle of entry to intersect th
upon the guide chosen. The vessel bifurcation is kept inferior to the probe at
plane, identifying the separation of the profunda femoral artery (PFA) and sup
femoral vein (FV). (C) The probe is moved superiorly until the common femora
vessel is kept under the central target line (green circles), which indicates theperator preference only. mFemoral angiograms were obtained in the 20- to 40-
egree ipsilateral oblique position without cranial or caudal
ngulation. A second view was obtained only if the first
ailed to adequately visualize the position of the catheter
elative to the CFA bifurcation. Placement of a vascular
losure device, choice of antithrombotic drugs, and sheath
ize was solely according to the discretion of the attending
hysician.
ollow-up. All patients were examined by blinded nursing
taff before discharge to assess for access site complications.
hart review and telephone contact was used to establish
he presence of complications at 30 days.
tudy end points. The primary end point of the study was
uccessful cannulation of the CFA, defined as above the
emoral bifurcation and below the origin of the inferior
pigastric artery. The secondary end points included the
ollowing procedural outcomes: first pass success rate, total
umber of attempts required for access, rate of accidental
enipunctures, and time to sheath insertion. The secondary
afety end point was any access complication, defined as:
ematoma 5 cm, pseudoaneurysm formation, retroperito-
eal hemorrhage, arterial dissection, vessel thrombosis,
oncoronary artery bypass graft-related access bleeding
equiring transfusion, access site infection, or hemoglobin
rop of 3 g/dl with an access source or 4 g/dl with an
nknown source.
Prespecified subgroups included obese patients (body
el at the imaging plane 1.5 cm, 2.5 cm, or 3.5 cm below the skin, depending
e of insertion. (B) The right femoral artery bifurcation is imaged in the axial
l femoral artery (SFA). Compression is used to differentiate arteries from the
ry (CFA) is visualized. During needle advancement, the anterior wall of the
of the needle.e vess
the tim
erﬁcia
l arteass index 30 kg/m2), peripheral vascular disease patients
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754ipsilateral stenosis of 50% by angiography), and patients
ith a high femoral artery bifurcation (occurring at or above
he inferior border of the femoral head).
ata analysis. Two blinded investigators reviewed the fem-
ral angiograms for proper CFA placement. A third senior
linded investigator adjudicated any disagreements. Angio-
rams were also analyzed for the position of the sheath,
FA bifurcation, and origin and most inferior reflection of
he inferior epigastric artery relative to the femoral head.
he CFA diameter was measured by comparison with the
heath, and the visible vessels were examined for evidence of
ignificant peripheral vascular disease.
Clinical outcomes were reviewed by an independent
linded clinical events committee who had access to the
elevant portions of medical records.
Collected data were analyzed on an intention-to-treat
asis. The unpaired Student’s t test or Wilcoxon rank sum
est was used for continuous variables, and the chi-square
est was used for proportions. The Fisher’s exact test was
sed for clinical outcomes. A 2-tailed p value of  0.05 was
sed for significance. Pre-specified subgroups were not
ubject to correction for multiple comparisons. Interactions
ere assessed with the Mantel-Haenszel test for homoge-
eity, and scatterplots were generated with STATA version
0 (StataCorp, College Station, Texas) software.
esults
atient population. Between April 2008 and February
009, 1,015 patients were enrolled and randomized. Eleven
atients no longer met the entry criteria by the time of their
rocedure and were excluded from the analysis but had no
linical events on follow-up. The remaining 1,004 patients
ere assigned to either fluoroscopic (n  501) or US (n 
03) guidance and included in the analysis of intraproce-
ural and clinical outcomes.
Baseline patient and procedural characteristics were sim-
lar between the fluoroscopic and US groups except for
obacco use (Table 1). There was no difference in operator
xperience, on the basis of year of fellowship training
Online Appendix). Closure device use was more frequent
n the US group (66.4% vs. 57.1%, p 0.01). Needle guides
ere used in 463 of 503 (92%) of US procedures.
On the request of the attending physician 5 fluoroscopy
atients crossed over to US, generally after 10 min and
ultiple attempts. A small number of patients (11 fluoros-
opy, 4 US) did not have an adequate femoral angiogram
erformed, leaving 989 patients available for angiogram
nalysis. Successful telephone or clinic follow-up was com-
leted in over 98% of patients in both groups.
ngiogram analysis. Successful CFA cannulation occurred
n 86.4% of US-guided procedures, compared with 83.3% of
uoroscopy guided procedures (p  0.17) (Fig. 2). Ultra-
ound lowered the rate of sheath insertion below the aifurcation of the CFA (7.0% vs. 11.8%, p  0.01) but had
nonsignificant trend toward high sticks (6.6% vs. 4.9%,
 0.25). Various alternative definitions of a high sheath
nsertion were used to analyze the angiograms, with no
ignificant difference in the rate of CFA insertions (Table 2). Of
he pre-specified subgroups, US showed a benefit in CFA
annulation only for the 31% of patients with a CFA
ifurcation occurring above the inferior border of the
emoral head (82.6% vs. 69.8%, p  0.01).
ntraprocedural outcomes. Compared with fluoroscopic
uidance, US guidance was associated with a reduced
umber of attempts, improved first pass success rate, re-
uced rate of venipuncture, and reduced time to access
Table 3). Ultrasound guidance with a needle guide was
Table 1. Baseline Patient and Procedural Characteristics
Characteristic
Fluoroscopy
(n  501)
Ultrasound
(n  503) p Value
Age, yrs 64.2 11.4 63.5 12.4 0.33
Male 366 (73.1) 371 (73.8) 0.80
White 329 (65.7) 352 (70.0) 0.14
Patient status
Outpatient 254 (50.7) 265 (52.8) 0.53
Inpatient 171 (34.1) 148 (29.5) 0.11
Outpatient admitted after procedure 76 (15.2) 89 (17.7) 0.28
BMI (kg/m2) 29.4 6.3 30.1 7.2 0.11
Obesity (BMI 30) 186 (37.1) 210 (41.7) 0.13
Morbid obesity (BMI 40) 31 (6.2) 41 (8.2) 0.23
Hypertension 427 (85.2) 426 (84.7) 0.81
Hypercholesterolemia 387 (77.2) 405 (80.5) 0.20
Diabetes mellitus 182 (36.3) 203 (50.3) 0.19
Tobacco 184 (36.7) 226 (44.9) 0.008
Creatinine 2.0 mg/dl* 9 (1.8) 9 (1.8) 0.99
End stage renal disease 10 (2.0) 15 (3.0) 0.31
Ipsilateral PVD 45 (9.2) 45 (9.0) 0.92
CFA diameter, mm 6.49 1.2 6.46 1.2 0.68
Procedural characteristics
Coronary angiogram 460 (91.8) 451 (89.7) 0.24
Peripheral angiogram 41 (8.2) 52 (10.3) 0.24
Intervention 161 (32.1) 155 (30.8) 0.65
Right heart catheterization 30 (6.0) 44 (8.7) 0.094
Sheath size 5.6 0.8 5.6 0.9 0.99
Fellow involved 470 (93.8) 468 (93.0) 0.62
Closure device used 286 (57.1) 332 (66.4) 0.004
Drugs used
Heparin† 199 (39.7) 211 (41.9) 0.47
Glycoprotein IIb/IIIa inhibitor 38 (7.6) 38 (7.6) 0.99
Bivalirudin 40 (8.0) 38 (7.6) 0.80
Clopidogrel 251 (50.1) 236 (46.9) 0.31
Values are presented as n (%) or mean  SD. *Patients on dialysis excluded. †Heparin includes
either unfractionated heparin and lowmolecular weight heparin.
BMI  body mass index; CFA  common femoral artery; PVD  peripheral vascular disease,
defined as50% stenosis by angiography.ssociated with a higher first pass success rate compared
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755ith US without a needle guide (83.8% vs. 70%, p  0.027)
Online Appendix).
linical outcomes. Clinical access complications occurred in
7 of 501 (3.4%) patients in the fluoroscopy group, com-
ared with 7 of 503 (1.4%) in the US-guided group
p  0.041) (Table 4). This result was driven by a signifi-
antly increased number of hematomas in the fluoroscopy
roup (11) versus the US group (3), p  0.034. No patients
uffered from access site infection, arteriovenous fistula
ormation, or retroperitoneal hemorrhage at 30 days. No
atient had a significant decrease in hemoglobin in the
bsence of transfusion. One patient suffered from both a
mall hematoma and a deep venous thrombosis 1 day after
ischarge; otherwise, all complications were evident by
ospital discharge. Among the hematoma complications, 7
4 fluoroscopy, 3 US) were observed by physician or nursing
Figure 2. Common Femoral Artery Placement Success
Ultrasound guidance did not demonstrate a signiﬁcantly superior rate of
sheath placement in the common femoral artery in the overall population
or the obese or peripheral vascular disease (PVD) subgroups. Ultrasound
guidance signiﬁcantly increased common femoral artery sheath placements
in the 31% of patients who had a femoral bifurcation over the femoral
head. *p  0.01.
Table 2. Sheath Placement According to Various Published Definitions
of a High Stick
Sheath Placement
Above the CFA Bifurcation and
Fluoroscopy
(n 490)
Ultrasound
(n  499) p Value
Below the origin of the IEA (6) 408 (83.3%) 431 (86.4%) 0.17
Below the most inferior reﬂection of
the IEA (4)
391 (79.8%) 401 (80.4%) 0.82
Below the top one-third of the
femoral head (5,7)
355 (72.4%) 361 (72.3%) 0.97
Below the top of the femoral head (6) 427 (87.1%) 447 (89.6%) 0.23
Anywhere over the femoral head (9) 407 (83.1%) 414 (83.0%) 0.98
Values are n (%). See references as noted.IEA inferior epigastric artery; other abbreviation as in Table 1.taff in or near the catheterization laboratory, and complete
linding could not be verified. Exclusion of these compli-
ations increased the statistical significance of the result
p  0.01). There was no significant interaction between
losure device use and bleeding complications (p  0.81).
earning curve. Greater experience with the US guidance
echnique was nonsignificantly associated with a higher rate
f successful CFA cannulation (Fig. 3). No pre-specified
ubgroup of US experience resulted in a significant improve-
ent in CFA cannulation compared with fluoroscopic
uidance; however, a trend was present. Increasing US
xperience was associated with a reduced time required for
ccess with US guidance. A cut point was selected, on the
asis of a scatterplot analysis (Online Appendix), to separate
xpert operators from novices. Operators with more than 10
rocedures had a mean access time of 158 s, compared with
68 s for novice operators (p  0.00001).
iscussion
his multicenter randomized controlled study demonstrates
hat routine real-time US guidance of femoral arterial access
oes not improve the rate of CFA cannulation, except in
atients with high CFA bifurcations.
Ultrasound guidance reduced the risk of vascular access
omplications by 59%, improved the first pass success rate to
2.7%, and nearly eliminated accidental venipunctures,
hile reducing the time required for access. The reduc-
ion in the rate of complications and average number of
Table 3. Intraprocedural Outcomes
Characteristic
Fluoroscopy
(n  500)
Ultrasound
(n  502) p Value
Number of attempts 3.0 3.2 1.3 0.9 0.000001
First pass success 232 (46.4%) 415 (82.7%) 0.000001
Venipuncture 79 (15.8%) 12 (2.4%) 0.000001
Number of arterial punctures 1.14 0.43 1.09 0.36 0.076
Mean time to insertion, s 213 194 185 175 0.016
Median time to insertion, s 148 (102–242) 136 (90–212) 0.003
Values are mean SD, n (%), or median (interquartile range).
Table 4. Vascular Access Complications
Complication
Fluoroscopy
(n  501)
Ultrasound
(n  503) p Value
Hematoma 5 cm 11 (2.2%) 3 (0.6%) 0.034
Pseudoaneurysm 0 1 NS
Dissection 3 2 NS
Access bleeding, transfusion 2 1 NS
Hematoma with DVT 1 0 NS
Any complication 17 (3.4%) 7 (1.4%) 0.041
Values are n (%) or n.DVT deep venous thrombosis.
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756ttempts is similar to the 57% risk reduction and the
eduction of 1.5 attempts seen in studies of internal
ugular vein cannulation (15). Our study, the largest study
f vascular access with US to date, extends the benefits to
emoral arterial access.
Ultrasound guidance significantly decreased the number
f low sticks, but a nonsignificant increase in high sticks
esulted in only a trend toward an improved CFA cannu-
ation rate. Our inclusion of operators with limited training
n US guidance likely hindered our ability to show a
ifference in CFA cannulation success. Despite the learning
urve with respect to this surrogate outcome, the other
enefits of US guidance were evident with even the limited
raining available.
US guidance demonstrated an increased CFA cannula-
ion rate in the 31% of patients with a CFA bifurcation
ccurring higher than the inferior border of the femoral
ead. Because this large subgroup of patients cannot be
dentified before catheterization in the absence of previous
ngiogram data, US guidance might necessarily be per-
ormed in all patients to achieve any CFA cannulation
enefit. Ultrasound guidance could therefore be helpful
here CFA cannulation is essential, namely for patients
ho require large sheaths for complex coronary or structural
Figure 3. CFA Cannulation Success by Ultrasound Experience
Increasing experience with ultrasound guidance demonstrated a trend
toward improved common femoral artery (CFA) cannulation success (p 
NS). Operators with the greatest experience had an 87.6% success rate with
ultrasound guidance, compared with an 83.3% success rate for ﬂuoroscopy
(p  0.076).nterventions or who require closure devices. pThe surrogate CFA outcome results did not adequately
eflect the benefit observed in actual complications and
ight reflect limitations in its utility. Femoral angiography
s limited in its accuracy for locating the precise point of
heath insertion, as it is dependent on maintaining proper
edial tension on the sheath, moving the sheath during the
njection, and setting the appropriate degree of oblique
ngulation. Moreover, although there is agreement that
heath placement above the anatomical inguinal ligament
ncreases the risk of retroperitoneal hemorrhage, the best
ngiographic correlates of the inguinal ligament are unclear
nd might vary from patient to patient. We tested our
esults according to several definitions of a high stick, none
f which showed a significant difference between fluoros-
opy and US.
The measurement of time to access in this study included
ime for injection of local anesthetic and imaging with
uoroscopy or US, in contrast to a previous study by
bu-Fadel et al. (10). The distributions of total attempts
nd time were positively skewed by difficult procedures in
oth fluoroscopy and US groups, with more outliers occur-
ing with fluoroscopy (Online Appendix). Despite minimiz-
ng the effect of outliers, the median time to access showed
significant difference between fluoroscopy and US groups.
his comparison excluded setup time for the US device to
ocus the measurement on the process of imaging and
btaining access. Sterile draping of the US probe and gel
pplication can be performed by catheterization lab staff;
owever, if setup time is included the total time to use US
uidance would be increased.
Closure device use was higher among patients receiving
S guidance. This difference was mediated in part by a
eduction in punctures below the CFA bifurcation, a reduc-
ion in multiple arterial punctures, and an increase in
unctures at or above the top one-third of the femoral head
ith US. After adjustment for these and other factors, US
uidance was not significantly associated with closure device
se (Online Appendix). Closure devices did not reduce
leeding complications in a meta-analysis of randomized
tudies (19), although nonrandomized studies of more
ecent devices have suggested a benefit (1,20). In this study
here was no significant interaction between closure device
se and risk of bleeding; hence the clinical benefit seen with
S guidance is not explained by the difference in closure
evice use.
Given the absence of significant differences in baseline
atient and procedural parameters or CFA cannulation
ates, the clinical benefit of US guidance is most likely
ediated by a reduction in tissue and vessel trauma from
ultiple attempts and venipunctures. Ultrasound guidance
s also more likely to achieve a true anterior wall puncture,
hich might allow for better arterial wall apposition and
ore appropriate seating of closure devices. Finally, manualressure applied to the artery during a standard cannulation
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757ight reduce its caliber, increasing the risk of a posterior or
ouble wall puncture. With US guidance, any compression
f the artery is both minimized and made visible during the
rocedure, potentially reducing the risk of a posterior wall
uncture.
The only previous trial of US in retrograde femoral
rterial access showed a modest benefit only in patients with
besity or a weak femoral pulse but was limited by a small
ample size, a lack of data on CFA cannulation rates, and a
otal of 2 operators (21). The equipment used required a
wivel arm to fix the probe, had no option for a needle
uide, and is obsolete by today’s standards.
The needle guide might be a critical tool for the US
echnique, because the needle is not generally visible until it
raverses the axial imaging plane. Longitudinal imaging is
n option to visualize the path of the needle, but generating
uch an image is difficult in the curved geometry of the
roin, as is maintaining the needle in the precise plane of the
S probe. Typical freehand axial US technique requires
hort forward and backward motions to project the path of
he needle, which might limit its accuracy for novice
perators. With a needle guide, if the image of the vessel is
ept in the center of the screen, the vessel will be under the
enter of the US probe, and the needle will almost invariably
nsert at the point imaged.
The use of a needle guide in this study was not random-
zed, with only the most experienced operators attempting
S guidance without one. Nevertheless needle guide use
as associated with a higher first pass success rate. Future
andomized studies would be necessary to confirm this
ifference.
tudy limitations. Blinding of the operator and catheteriza-
ion lab personnel to the study intervention was not possi-
le. Despite the use of a second observer and lab timer, we
annot completely exclude a bias in the performance or
easurement of the number of attempts, venipunctures, or
ime to access. Our results are specific to a high-quality US
ystem with a needle guide and large screen and might not
e generalizable to other systems. Because this trial was
onducted at teaching hospitals, most of procedures in-
olved cardiology fellows. However, US guidance main-
ained a benefit among procedures performed by attend-
ng physicians and interventional fellows (Online
ppendix). We did not test the combination of fluoros-
opy and US, which might increase the probability of
nserting the sheath over the femoral head (10).
Finally, in this study the clinical benefit of US guidance
as driven primarily by a reduction in hematomas 5 cm.
lthough 2 large contemporary randomized trials
ACUITY [Acute Catheterization and Urgent Intervention
nd Triage Strategy], HORIZONS-AMI [Harmonizing
utcomes With Revascularization and Stents in Acute
yocardial Infarction]) (22,23), included hematomas 5m as a component of non–coronary artery bypass graft-elated major bleeding, such hematomas were not associated
ith an increase in mortality in a recent pooled analysis of
he same trials (hazard ratio: 1.30, p  NS) (24). Hemato-
as were found to be associated with decreased hemoglobin
ounts but not with transfusions or mortality in the
TEEPLE (SafeTy and Efficacy of Enoxaparin in Percu-
aneous coronary intervention patients, an internationaL
andomized Evaluation) trial (25). Many of these hemato-
as do not require intervention aside from prolonged
anual pressure, bed rest, and observation; nevertheless, a
ost-estimation analysis by Resnic et al. (3) found the
ttributable cost of such treatment to be $1,399 per com-
lication. Patient discomfort and the rate of premature
iscontinuation of antithrombotic agents would likely be
ncreased from management of hematomas, but to our
nowledge this has not been specifically studied.
ost-effectiveness. We did not directly measure the costs
ssociated with US guidance in this study. Ultrasound has
een previously estimated by the National Institute for
linical Excellence to save £2,000 for every 1,000 central
enous procedures (26). For an incremental cost of dispos-
bles of $17 per patient and an attributable cost of $1,399 to
reat a hematoma (3), we estimate that excluding initial
ardware costs of $17,000 US guidance could potentially
ave $550 for every 50 patients in which it was used for
emoral arterial access.
onclusions
n this multicenter randomized trial of femoral arterial
ccess, US guidance facilitated successful arterial access and
educed clinical complications. The rate of sheath insertion
nto the CFA was increased in patients with a high CFA
ifurcation but not in the overall population. Ultrasound
uidance should be considered for any patient at high risk
or a difficult access or complications.
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